TJ
TOBIN JAMES R
Director
BoardM
Insider track record
Board DirectorAcross 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by TOBIN JAMES R, Director. Director active across 2 companies, notably Globus Medical INC. Cumulatively, 19 disclosures have been logged. Split: 0 buy · 9 sells. Total volume traded: €9.8m. Activity tracked since 10 May 2021. The latest transaction was filed on 22 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
2,134 shares0Common StockSEC:0000950170-25-077221:0
18,000 shares0Common StockSEC:0000950170-24-107493:0
12,664 shares@ US$158.9618.7% of flowCommon StockSEC:0000950170-24-094806:0
732 shares0Common StockSEC:0000950170-24-065398:0
5,130 shares@ US$124.766.1% of flowCommon StockSEC:0000950170-24-054600:0
11,236 shares@ US$105.7011.3% of flowCommon StockSEC:0000950170-24-052972:0
200 shares@ US$81.410.2% of flowCommon StockSEC:0000950170-24-026472:0
10,000 shares@ US$70.146.5% of flowCommon StockSEC:0000950170-23-066771:0
1,193 shares0Common StockSEC:0000950170-23-024887:0
10,000 shares@ US$75.137.2% of flowCommon StockSEC:0000899243-23-006281:0
48,515 shares@ US$39.9819.3% of flowCommon StockSEC:0000899243-22-027253:0
48,515 shares@ US$35.0016.8% of flowCommon StockSEC:0000899243-22-025482:0
48,516 shares@ US$29.940.033% mcap100.0% of flowCommon StockSEC:0000899243-22-017085:0
5,308 shares@ US$43.580.0020% mcap9.6% of flowClass A Common StockSEC:0001209191-22-019620:0
4,484 shares@ US$43.580.0017% mcap8.2% of flowClass A Common StockSEC:0001209191-22-018065:0
25,500 shares0Common StockSEC:0000899243-21-048617
25,500 shares0Common StockSEC:0000899243-21-048617:0
25,000 shares@ US$43.770.0087% mcap41.1% of flowClass A Common StockSEC:0001209191-21-032071:0
25,000 shares@ US$43.7741.1% of flowClass A Common StockSEC:0001209191-21-032071
About TOBIN JAMES R
James R. Tobin is a Board Member at Globus Medical Inc and TransMedics Group, Inc. He brings valuable expertise in corporate governance and strategy. As a board member, he contributes to the strategic direction of both companies, aiding their success in the medical device market.